Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1

Interventions

Letrozole 34Fulvestrant 31Specimen Handling 29ribociclib 22pembrolizumab 22Paclitaxel 21Magnetic Resonance Spectroscopy 20palbociclib 19Trastuzumab 19Anastrozole 19Carboplatin 18Capecitabine 18exemestane 17abemaciclib 16Biopsy 16Tamoxifen 15pertuzumab 14trastuzumab deruxtecan 12Cyclophosphamide 10Taxes 9Radiotherapy 8Goserelin 8Docetaxel 8giredestrant 7Standard of Care 7130-nm albumin-bound paclitaxel 7inavolisib 6eribulin 6elacestrant 6atezolizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Magnetic Resonance Imaging × Breast × 30 days × Clear all
NCT07277738 2026-05-20

PSID

Washington University School of Medicine

Phase NA Not yet recruiting
78 enrolled
Breast

Breast Neoplasms

NCT05115474 2026-05-18

Study of Screening Brain MRIs in Stage IV Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
170 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

University of Wisconsin, Madison

Phase 2 Recruiting
53 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡